Role of Obesity-induced Inflammation in the Development of Insulin Resistance and Type 2 Diabetes: History of the Research and Remaining Questions

Overview

Journal Ann Pediatr Endocrinol Metab

Specialty Pediatrics

Date 2021 Apr 5

PMID 33819954

Citations 21

Authors

Jieun Kim

Jongsoon Lee

Affiliations

Soon will be listed here.

Abstract

The prevalence of obesity has increased alarmingly both worldwide and in Korea. This has also dramatically increased the prevalence of chronic obesity-associated diseases, including type 2 diabetes (T2D). Extensive studies on the molecular etiology of T2D have revealed several potential mechanisms by which obesity induces the development of insulin resistance and T2D. One of these is low-grade chronic inflammation. Studies hinting at the existence of this phenomenon were first published about 30 years ago. Ten years later, several seminal papers confirmed its existence, which then led to a rapid and massive escalation of research in this field. Today, the notion that obesity-induced inflammation mediates T2D is now well-accepted. This paper will review the key developments in this field, including the discovery that obesity-induced inflammation and insulin resistance is mainly regulated by adipose tissue-resident immune cells, particularly those in visceral adipose tissue. This review further details the research areas, including (1) the obesity-related factors that induce adipose tissue macrophage (ATM) inflammation, (2) the precise effector functions by which adipose tissue immune cells promote insulin resistance, (3) whether there are early immunological events that have an outsize effect on later events and could be targeted to arrest the development of insulin resistance, (4) the roles played by nonimmunological functions of ATMs and other immune cells, and (5) whether there are noncanonical immune responses to obesity (i.e., immune responses that are unique to obesity and cannot be detected by following the discoveries in the classical immunity field).

Citing Articles

Diabetes Mellitus and Cardiovascular Disease: Exploring Epidemiology, Pathophysiology, and Treatment Strategies.

Siam N, Snigdha N, Tabasumma N, Parvin I Rev Cardiovasc Med. 2025; 25(12):436.

PMID: 39742220 PMC: 11683709. DOI: 10.31083/j.rcm2512436.

Ramadan Intermittent Fasting and Plasma Volume Variations in Individuals with Different Body Weights.

Khalfoun J, Zouhal H, Triki R, Jribi W, Saeidi A, Almaqhawi A Medicina (Kaunas). 2024; 60(7).

PMID: 39064573 PMC: 11278820. DOI: 10.3390/medicina60071143.

Usefulness of glycated albumin level as a glycemic index complementing glycosylated hemoglobin in diabetic children and adolescents.

Choi Y, Lee N, Ahn M, Kim S, Cho W, Cho K Ann Pediatr Endocrinol Metab. 2024; 28(4):289-295.

PMID: 38173383 PMC: 10765020. DOI: 10.6065/apem.2244202.101.

Commentary on "Effects of once-weekly dulaglutide on juvenile type 2 diabetes mellitus and obesity in Korea: a pilot study".

Lim H Ann Pediatr Endocrinol Metab. 2024; 28(4):235-236.

PMID: 38173379 PMC: 10765026. DOI: 10.6065/apem.2322098edi010.

Trends in HOMA-IR values among South Korean adolescents from 2007-2010 to 2019-2020: a sex-, age-, and weight status-specific analysis.

Kim S, Song K, Lee M, Suh J, Chae H, Kim H Int J Obes (Lond). 2023; 47(9):865-872.

PMID: 37443273 PMC: 10439007. DOI: 10.1038/s41366-023-01340-2.

References

Cai D, Yuan M, Frantz D, Melendez P, Hansen L, Lee J . Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005; 11(2):183-90. PMC: 1440292. DOI: 10.1038/nm1166. View

Cereijo R, Gavalda-Navarro A, Cairo M, Quesada-Lopez T, Villarroya J, Moron-Ros S . CXCL14, a Brown Adipokine that Mediates Brown-Fat-to-Macrophage Communication in Thermogenic Adaptation. Cell Metab. 2018; 28(5):750-763.e6. DOI: 10.1016/j.cmet.2018.07.015. View

Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J . Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med. 2009; 15(8):921-9. PMC: 3063199. DOI: 10.1038/nm.2001. View

Medzhitov R, Preston-Hurlburt P, Janeway Jr C . A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997; 388(6640):394-7. DOI: 10.1038/41131. View

Zuniga L, Shen W, Joyce-Shaikh B, Pyatnova E, Richards A, Thom C . IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol. 2010; 185(11):6947-59. PMC: 3001125. DOI: 10.4049/jimmunol.1001269. View

Winer D, Winer S, Shen L, Wadia P, Yantha J, Paltser G . B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 2011; 17(5):610-7. PMC: 3270885. DOI: 10.1038/nm.2353. View

OSullivan T, Rapp M, Fan X, Weizman O, Bhardwaj P, Adams N . Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance. Immunity. 2016; 45(2):428-41. PMC: 5004886. DOI: 10.1016/j.immuni.2016.06.016. View

Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A . Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med. 2009; 15(8):930-9. PMC: 3115752. DOI: 10.1038/nm.2002. View

Hotamisligil G, Peraldi P, Budavari A, Ellis R, White M, Spiegelman B . IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996; 271(5249):665-8. DOI: 10.1126/science.271.5249.665. View

10.

Tanaka M, Ikeda K, Suganami T, Komiya C, Ochi K, Shirakawa I . Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis. Nat Commun. 2014; 5:4982. DOI: 10.1038/ncomms5982. View

11.

Ridker P, Cushman M, Stampfer M, Tracy R, Hennekens C . Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997; 336(14):973-9. DOI: 10.1056/NEJM199704033361401. View

12.

Nishimura S, Manabe I, Takaki S, Nagasaki M, Otsu M, Yamashita H . Adipose Natural Regulatory B Cells Negatively Control Adipose Tissue Inflammation. Cell Metab. 2013; 18(5):759-766. DOI: 10.1016/j.cmet.2013.09.017. View

13.

Cai D, Frantz J, Tawa Jr N, Melendez P, Oh B, Lidov H . IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell. 2004; 119(2):285-98. DOI: 10.1016/j.cell.2004.09.027. View

14.

Xu X, Grijalva A, Skowronski A, van Eijk M, Serlie M, Ferrante Jr A . Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab. 2013; 18(6):816-30. PMC: 3939841. DOI: 10.1016/j.cmet.2013.11.001. View

15.

Molofsky A, Nussbaum J, Liang H, Van Dyken S, Cheng L, Mohapatra A . Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med. 2013; 210(3):535-49. PMC: 3600903. DOI: 10.1084/jem.20121964. View

16.

Lumeng C, Bodzin J, Saltiel A . Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007; 117(1):175-84. PMC: 1716210. DOI: 10.1172/JCI29881. View

17.

Lee B, Lee J . Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta. 2013; 1842(3):446-62. PMC: 3800253. DOI: 10.1016/j.bbadis.2013.05.017. View

18.

Mehta P, Nuotio-Antar A, Smith C . γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice. J Leukoc Biol. 2014; 97(1):121-34. PMC: 4377824. DOI: 10.1189/jlb.3A0414-211RR. View

19.

Uysal K, Wiesbrock S, Marino M, Hotamisligil G . Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 1997; 389(6651):610-4. DOI: 10.1038/39335. View

20.

Knowler W, Fowler S, Hamman R, Christophi C, Hoffman H, Brenneman A . 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009; 374(9702):1677-86. PMC: 3135022. DOI: 10.1016/S0140-6736(09)61457-4. View